 |  |  |
|---|---|---|
 |  |  |
 |  |  |
 |  |  |
With 27 years of experience in conducting HIV research including HIV vaccine, HIV biomedical prevention
and treatment in various populations to develop academic knowledge on HIV / AIDS,
we have worked in collaboration with leading international research networks and other domestic agencies.
Our diverse research programs are up-to-date with present situation and necessity of knowledge both nationally and globally
We are ready to expand our field of expertise to other challenging infectious diseases and substance use
News and Activities
To find more information, click the image
October 08 and October 22, 2020
The HPTN 083 study team visited the Caremat Health Center and Mplus foundation, the community based organizations actively working on HIV prevention for MSMs/TGs and adolescentsSeptember 28 -29, 2020
Knowledge Sharing Meeting: Exploratory and Qualitative Research in Hard-to-Reach Populations in Songkhla ProvinceAugust 26 -28, 2020
Dr. Arunrat Tangmunkongvorakul, as a speaker for a training “How to Conduct Qualitative Research in HIV and Other Health Priorities” at Thai Red Cross AIDS Research Center, BangkokAugust 14, 2020
"Chang for Life" project organized by Gang SAA at the children and youth training center Region 7, Chiang MaiJuly 24, 2020
Community Relation Unit newsletter July-September 2020 has been issued. Click the image to read moreResearch report
HIV Integrated Behavioral and Biological Surveillance Surveys Among People Who Inject Drugs:Chiang Mai, Thailand-2019Survey Results
Illegal Liqour in Thai SocietyJune 23, 2020
Gang SAA (Substance abuse unit) activities for International Day against Drug Abuse and Illicit Trafficking June 26, 2020May 18, 2020
HPTN 083 Results Released: Long-Acting Injectable drug proves highly effective for HIV prevention in MSM/TGResearch Studies Currently Underway
To learn more, click Study title (to visit webpage) or Study snapshot (in Thai)
This study will evaluate if a double dose (3.0 mg) of levonorgestrel (LNG) emergency contraception (EC) overcomes known drug-drug interactions with
efavirenz-based antiretroviral therapy (ART) or rifampicin-containing tuberculosis (TB) therapy
What the body of HIV-infected adolescents do to these new drugs?
Are they safe for this population?
Doravirine (DOR) and
Doravirine, lamivudine, and
tenofovir disoproxil fumarate
fixed dose combination (DOR/3TC/TDF)
We are looking for healthy male volunteers , 20 to 45 years of age
The main purpose of this study is to test whether the three doses schedule of the 9 valent HPV vaccine is safe and works to prevent the oral persistent infections with human papillomavirus (HPV) types that carry a high oncogenic risk
Contact Us
Research Institute for Health Sciences, Chiang Mai University
110 Intavaroros Road, Sriphum, Muang
Chiang Mai 50200 THAILAND
Tel. 66 5393 6148
